Search Results 151-160 of 1177 for 贵阳软件开发公司 www.w-t.cn

  1. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to severely ...

  2. A Study to Evaluate the Use of a Novel Wearable Device for Temperature Monitoring in Cancer Patients Who Underwent Autologous Stem Cell Transplant - Mayo Clinic

    The purpose of this study is to evaluate the performance of the wearable tPatch device when compared to an oral temperature measuring device in patients who ...

  3. https://www.mayoclinic.org/arabic_patient_consumer_web.xml

  4. Patents - Mitochondrial Neurobiology and Therapeutics Laboratory - Mayo Clinic Research

    Eugenia Trushina, Ph.D., and research collaborators in her Mitochondrial Neurobiology and Therapeutics Lab at Mayo Clinic have created patent-pending ...

  5. A Study to Assess Biomarkers of Cerebral Cavernous Angioma with Symptomatic Hemorrhage (CASH) - Mayo Clinic

    The purpose of this study is to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas, a ...

  6. M6620 First in Human Study - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. Deuterated Phenanthrene Tetraol in Smokers Who Are at High Risk For Lung Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Electronic Patient Reporting of Symptoms During Cancer Treatment - Mayo Clinic

    The current study is designed to test nationally whether patients' outcomes and utilization of services can be improved through symptom monitoring via patient- ...

  9. Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis - Mayo Clinic

    Dose escalation study to determine the maximum tolerated dose of NEOD001 in approximately 30 subjects with AL amyloidosis. Expansion phase to evaluate safety, ...

  10. Tools to evaluate treatment tolerability in older patients with sarcoma - Mayo Clinic

    We hypothesize that clinical screening tools and laboratory tests can help evaluate older patients (age 65 years and above) with advanced/metastatic sarcoma who ...